Head-to-head · WeighScore
RegenCen vs VyrarX
The verdict
VyrarX takes it — 68.6/100 to 59.8/100.
VyrarX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | RegenCen | VyrarX |
|---|---|---|
| WeighScore | 59.8/100 | 68.6/100 |
| Grade | C | C |
| Scorecard rank | #334 | #145 |
| Semaglutide | Not disclosed | $179/mo (starting dose, compounded) |
| Tirzepatide | Not disclosed | $329/mo (starting dose, compounded) |
| Coverage | 2 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #334 · C
Strengths
- Virtual consultations by video or phone for MI and FL patients
- MD-led oversight (Dr. Gustav Lo) plus PA co-founder
- Menopause Society Certified Practitioners on staff
- GLP-1 paired with coaching and metabolic care
- Bundles weight loss with bioidentical hormone therapy
Where it loses points
- Telehealth limited to Michigan and Florida
- No published GLP-1 medication pricing
- No named pharmacy or medication sourcing details
- Menopause/women's focus rather than weight-loss-only
Graded #145 · C
Strengths
- LegitScript certified with active seal (ID 51177727)
- Semaglutide starting at $179/month with free shipping included
- 1:1 direct provider messaging and personalized titration plan in every plan
- Nutrition coaching included with the weight-loss program
- Provider review completed within 24 hours; no insurance required
Where it loses points
- Tirzepatide at $329/month starting is at the high end of the compounded market
- Compounding pharmacy not named on any public page
- No physician names or clinical leadership disclosed publicly
- Only 47 states covered — the 3 excluded states are not named on the site
- Labs not included in the weight-loss plan
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.